Sailong Pharmaceutical: Announcement on participating in the tenth batch of centralized national drug procurement and planning to win the bid
Sailong Pharmaceutical: Announcement on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Sailong Pharmaceutical: Announcement on cancellation of pledges for shareholders\' shares holding 5% or more
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for esprolol hydrochloride injection
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a fluorouracil injection drug registration certificate
Sailong Pharmaceutical: Announcement on the expiration of the share reduction plan for shareholders holding 5% or more of the shares
Sailong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining the “Notice of Approval of the Drug Supplement Application”
Sailong Pharmaceutical: Announcement on changes in equity of shareholders holding 5% or more of the shares to 1%
Sailong Pharmaceutical: Announcement on preparation for impairment calculation for the first three quarters of 2024
Cailong Pharmaceutical: Announcement of Board Resolutions
Sailong Pharmaceutical: Review Opinions of the Third Meeting of the Fourth Board Audit Committee in 2024
Sailong Pharmaceutical: Explanation of the Supervisory Board on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceuticals: Report for the third quarter of 2024
Cailong Pharmaceutical: Announcement of Supervisory Board Resolutions
Sailong Pharmaceutical: Explanation of the Board of Directors and Audit Committee on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceutical: Announcement on the Election of the Chairman of the Supervisory Board
Sailong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Supervisors
Sailong Pharmaceutical: Legal Opinion on the 2024 Fourth Extraordinary General Meeting of Shareholders of Sailong Pharmaceutical Group Co., Ltd.
Cailong Pharmaceutical: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Sailong Pharmaceutical: Announcement on completing the by-election of non-employee representative supervisors of the 4th board of supervisors
No Data